Atom Investors’s Replimune Group REPL Stock Holding History

Atom Investors’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-66,071	Closed	-$595K	–	582
2024 Q2	$595K	Buy	+66,071	New	+$460K	0.06%	316

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atom Investors's REPL Position: Q3 2024 in Review

Atom Investors sold out of Replimune Group (REPL) in Q3 2024, closing a stake of 66,071 shares — an estimated $595K sold.

Atom Investors first reported a position in REPL in Q2 2024 and held it in 1 quarter. The position peaked at $595K in Q2 2024. 144 funds tracked by Wall St. Rank hold REPL as of Q3 2024.

Atom Investors reported no remaining Replimune Group position as of Q3 2024 after selling out during the quarter.
Atom Investors sold 66,071 Replimune Group shares in Q3 2024, an estimated $595K.
Atom Investors first reported a position in Replimune Group in Q2 2024 and held it in 1 quarter.
Atom Investors's Replimune Group position peaked at $595K in Q2 2024.
144 funds tracked by Wall St. Rank held Replimune Group as of Q3 2024.

Based on Atom Investors's 13F filing for Q3 2024, filed 14 Nov 2024.